Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Total 13F shares
-
83,866,177
-
Share change
-
-8,396,796
-
Total reported value
-
$12,392,166,611
-
Put/Call ratio
-
73%
-
Price per share
-
$147.87
-
Number of holders
-
634
-
Value change
-
-$1,756,114,895
-
Number of buys
-
284
-
Number of sells
-
360
Institutional Holders of RESMED INC - Common Stock (RMD) as of Q3 2023
As of 30 Sep 2023 RESMED INC - Common Stock (RMD) had 634 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 83,866,177 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., CITADEL ADVISORS LLC, NORTHERN TRUST CORP, NORGES BANK, and Bank of New York Mellon Corp.
This table shows 644 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.